Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Total Non-Current Liabilities (2023 - 2026)

Beta Bionics' Total Non-Current Liabilities history spans 4 years, with the latest figure at $31.6 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 32.43% to $31.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $31.6 million, a 32.43% increase, with the full-year FY2025 number at $39.6 million, up 37.77% from a year prior.
  • Total Non-Current Liabilities hit $31.6 million in Q1 2026 for Beta Bionics, down from $39.6 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for BBNX hit a ceiling of $39.6 million in Q4 2025 and a floor of $23.9 million in Q1 2025.
  • Historically, Total Non-Current Liabilities has averaged $30.6 million across 4 years, with a median of $29.1 million in 2023.
  • Biggest five-year swings in Total Non-Current Liabilities: fell 1.3% in 2024 and later skyrocketed 37.77% in 2025.
  • Tracing BBNX's Total Non-Current Liabilities over 4 years: stood at $29.1 million in 2023, then fell by 1.3% to $28.7 million in 2024, then skyrocketed by 37.77% to $39.6 million in 2025, then dropped by 20.14% to $31.6 million in 2026.
  • Business Quant data shows Total Non-Current Liabilities for BBNX at $31.6 million in Q1 2026, $39.6 million in Q4 2025, and $34.1 million in Q3 2025.